Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

The success of CAR-T cells for treating acute myeloid leukaemia (AML) is hampered by toxicity to normal cells and low CAR-T cell persistence. Here, the authors show that the demethylating compound 5′-Azacitdine increases anti-CD123 CAR-T cell cytotoxicity against AML.

Guardado en:
Detalles Bibliográficos
Autores principales: Nadia El Khawanky, Amy Hughes, Wenbo Yu, Renier Myburgh, Tony Matschulla, Sanaz Taromi, Konrad Aumann, Jade Clarson, Janaki Manoja Vinnakota, Khalid Shoumariyeh, Cornelius Miething, Angel F. Lopez, Michael P. Brown, Justus Duyster, Lutz Hein, Markus G. Manz, Timothy P. Hughes, Deborah L. White, Agnes S. M. Yong, Robert Zeiser
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/fe5a9441efac4b52a10770a66f35954d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe5a9441efac4b52a10770a66f35954d
record_format dspace
spelling oai:doaj.org-article:fe5a9441efac4b52a10770a66f35954d2021-11-14T12:36:27ZDemethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia10.1038/s41467-021-26683-02041-1723https://doaj.org/article/fe5a9441efac4b52a10770a66f35954d2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-26683-0https://doaj.org/toc/2041-1723The success of CAR-T cells for treating acute myeloid leukaemia (AML) is hampered by toxicity to normal cells and low CAR-T cell persistence. Here, the authors show that the demethylating compound 5′-Azacitdine increases anti-CD123 CAR-T cell cytotoxicity against AML.Nadia El KhawankyAmy HughesWenbo YuRenier MyburghTony MatschullaSanaz TaromiKonrad AumannJade ClarsonJanaki Manoja VinnakotaKhalid ShoumariyehCornelius MiethingAngel F. LopezMichael P. BrownJustus DuysterLutz HeinMarkus G. ManzTimothy P. HughesDeborah L. WhiteAgnes S. M. YongRobert ZeiserNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Nadia El Khawanky
Amy Hughes
Wenbo Yu
Renier Myburgh
Tony Matschulla
Sanaz Taromi
Konrad Aumann
Jade Clarson
Janaki Manoja Vinnakota
Khalid Shoumariyeh
Cornelius Miething
Angel F. Lopez
Michael P. Brown
Justus Duyster
Lutz Hein
Markus G. Manz
Timothy P. Hughes
Deborah L. White
Agnes S. M. Yong
Robert Zeiser
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
description The success of CAR-T cells for treating acute myeloid leukaemia (AML) is hampered by toxicity to normal cells and low CAR-T cell persistence. Here, the authors show that the demethylating compound 5′-Azacitdine increases anti-CD123 CAR-T cell cytotoxicity against AML.
format article
author Nadia El Khawanky
Amy Hughes
Wenbo Yu
Renier Myburgh
Tony Matschulla
Sanaz Taromi
Konrad Aumann
Jade Clarson
Janaki Manoja Vinnakota
Khalid Shoumariyeh
Cornelius Miething
Angel F. Lopez
Michael P. Brown
Justus Duyster
Lutz Hein
Markus G. Manz
Timothy P. Hughes
Deborah L. White
Agnes S. M. Yong
Robert Zeiser
author_facet Nadia El Khawanky
Amy Hughes
Wenbo Yu
Renier Myburgh
Tony Matschulla
Sanaz Taromi
Konrad Aumann
Jade Clarson
Janaki Manoja Vinnakota
Khalid Shoumariyeh
Cornelius Miething
Angel F. Lopez
Michael P. Brown
Justus Duyster
Lutz Hein
Markus G. Manz
Timothy P. Hughes
Deborah L. White
Agnes S. M. Yong
Robert Zeiser
author_sort Nadia El Khawanky
title Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
title_short Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
title_full Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
title_fullStr Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
title_full_unstemmed Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
title_sort demethylating therapy increases anti-cd123 car t cell cytotoxicity against acute myeloid leukemia
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/fe5a9441efac4b52a10770a66f35954d
work_keys_str_mv AT nadiaelkhawanky demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT amyhughes demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT wenboyu demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT reniermyburgh demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT tonymatschulla demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT sanaztaromi demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT konradaumann demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT jadeclarson demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT janakimanojavinnakota demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT khalidshoumariyeh demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT corneliusmiething demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT angelflopez demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT michaelpbrown demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT justusduyster demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT lutzhein demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT markusgmanz demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT timothyphughes demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT deborahlwhite demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT agnessmyong demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
AT robertzeiser demethylatingtherapyincreasesanticd123cartcellcytotoxicityagainstacutemyeloidleukemia
_version_ 1718429145727238144